Health Canada has reminded hospitals that Anzemet [dolasetron] is contraindicated in patients aged < 18 years Correspondence 21 January 2013 Pages: 2 - 2
The French medicines regulator Afssaps has warned prescribers about the potential non-Hodgkin's lymphoma risk with off-label infliximab Clinical study 21 January 2013 Pages: 2 - 2
Ketek's labelling to include new safety information, says US FDA Media release 21 January 2013 Pages: 2 - 2
The UK MHRA has received seven reports suggesting an interaction between glucosamine and warfarin News item 21 January 2013 Pages: 3 - 3
The Yellow Card Scheme for reporting adverse drug reactions (ADRs) by patients in the UK will complement, not replace, the Yellow Card reports Clinical study 21 January 2013 Pages: 3 - 3
Viagra, Levitra and Cialis safety information visible in Canada News item 21 January 2013 Pages: 3 - 3
Anadys Pharmaceuticals, Inc. has suspended dosing of ANA 975 in patients with hepatitis C virus infection in its ongoing phase Ib clinical trial Media release 21 January 2013 Pages: 3 - 3
Health Canada is advising women not to use ACE inhibitors during pregnancy due to the risk of birth defects Media release 21 January 2013 Pages: 3 - 3
Amoxicillin/clavulanic acid: false positive Fungitell assay results Correspondence 21 January 2013 Pages: 5 - 5
Measles mumps and rubella virus vaccine/tick borne encephalitis vaccine Case report 21 January 2013 Pages: 15 - 15
